Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community.
Aged
Aged, 80 and over
Diastole
Female
Health Status
Heart Failure
/ diagnosis
Humans
Male
Mass Screening
Middle Aged
Predictive Value of Tests
Primary Health Care
Prognosis
Reproducibility of Results
Risk Assessment
Risk Factors
Stroke Volume
Ventricular Dysfunction, Left
/ diagnosis
Ventricular Function, Left
Screening
community
heart failure with preserved ejection fraction
left ventricular diastolic dysfunction
sex
Journal
European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
pubmed:
30
11
2018
medline:
20
8
2020
entrez:
29
11
2018
Statut:
ppublish
Résumé
The prevalence of undetected left ventricular diastolic dysfunction is high, especially in the elderly with comorbidities. Left ventricular diastolic dysfunction is a prognostic indicator of heart failure, in particularly of heart failure with preserved ejection fraction and of future cardiovascular and all-cause mortality. Therefore we aimed to develop sex-specific diagnostic models to enable the early identification of men and women at high-risk of left ventricular diastolic dysfunction with or without symptoms of heart failure who require more aggressive preventative strategies. Individual patient data from four primary care heart failure-screening studies were analysed (1371 participants, excluding patients classified as heart failure and left ventricular ejection fraction <50%). Eleven candidate predictors were entered into logistic regression models to be associated with the presence of left ventricular diastolic dysfunction/heart failure with preserved ejection fraction in men and women separately. Internal-external cross-validation was performed to develop and validate the models. Increased age and β-blocker therapy remained as predictors in both the models for men and women. The model for men additionally consisted of increased body mass index, moderate to severe shortness of breath, increased pulse pressure and history of ischaemic heart disease. The models performed moderately and similarly well in men (c-statistics range 0.60-0.75) and women (c-statistics range 0.51-0.76) and the performance improved significantly following the addition of N-terminal pro b-type natriuretic peptide (c-statistics range 0.61-0.80 in women and 0.68-0.80 in men). We provide an easy-to-use screening tool for use in the community, which can improve the early detection of left ventricular diastolic dysfunction/heart failure with preserved ejection fraction in high-risk men and women and optimise tailoring of preventive interventions.
Sections du résumé
BACKGROUND
The prevalence of undetected left ventricular diastolic dysfunction is high, especially in the elderly with comorbidities. Left ventricular diastolic dysfunction is a prognostic indicator of heart failure, in particularly of heart failure with preserved ejection fraction and of future cardiovascular and all-cause mortality. Therefore we aimed to develop sex-specific diagnostic models to enable the early identification of men and women at high-risk of left ventricular diastolic dysfunction with or without symptoms of heart failure who require more aggressive preventative strategies.
DESIGN
Individual patient data from four primary care heart failure-screening studies were analysed (1371 participants, excluding patients classified as heart failure and left ventricular ejection fraction <50%).
METHODS
Eleven candidate predictors were entered into logistic regression models to be associated with the presence of left ventricular diastolic dysfunction/heart failure with preserved ejection fraction in men and women separately. Internal-external cross-validation was performed to develop and validate the models.
RESULTS
Increased age and β-blocker therapy remained as predictors in both the models for men and women. The model for men additionally consisted of increased body mass index, moderate to severe shortness of breath, increased pulse pressure and history of ischaemic heart disease. The models performed moderately and similarly well in men (c-statistics range 0.60-0.75) and women (c-statistics range 0.51-0.76) and the performance improved significantly following the addition of N-terminal pro b-type natriuretic peptide (c-statistics range 0.61-0.80 in women and 0.68-0.80 in men).
CONCLUSIONS
We provide an easy-to-use screening tool for use in the community, which can improve the early detection of left ventricular diastolic dysfunction/heart failure with preserved ejection fraction in high-risk men and women and optimise tailoring of preventive interventions.
Identifiants
pubmed: 30482050
doi: 10.1177/2047487318816774
pmc: PMC6431757
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
613-623Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
J Am Coll Cardiol. 2001 Mar 15;37(4):1042-8
pubmed: 11263606
J Clin Epidemiol. 2002 Jul;55(7):633-6
pubmed: 12160909
JAMA. 2003 Jan 8;289(2):194-202
pubmed: 12517230
J Am Coll Cardiol. 2004 Feb 4;43(3):317-27
pubmed: 15013109
Eur Heart J. 2005 Sep;26(18):1887-94
pubmed: 15860516
Heart. 2006 Sep;92(9):1259-64
pubmed: 16488928
Am J Cardiol. 2006 Jul 1;98(1):116-20
pubmed: 16784933
Eur Heart J. 2007 Oct;28(20):2539-50
pubmed: 17428822
Circ Heart Fail. 2009 Mar;2(2):105-12
pubmed: 19808325
BMC Public Health. 2009 Dec 21;9:479
pubmed: 20025758
JAMA. 2011 Aug 24;306(8):856-63
pubmed: 21862747
Curr Opin Cardiol. 2011 Nov;26(6):562-8
pubmed: 21993357
Circulation. 2011 Dec 20;124(25):2865-73
pubmed: 22104551
Cardiovasc Ultrasound. 2012 Mar 19;10:10
pubmed: 22429658
JAMA. 2013 Jul 3;310(1):66-74
pubmed: 23821090
N Engl J Med. 2014 Apr 10;370(15):1383-92
pubmed: 24716680
Eur J Heart Fail. 2014 Jul;16(7):772-7
pubmed: 24863953
J Am Board Fam Med. 2014 Nov-Dec;27(6):811-21
pubmed: 25381079
J Clin Epidemiol. 2016 Jan;69:245-7
pubmed: 25981519
J Am Heart Assoc. 2016 Jan 25;5(1):null
pubmed: 26811160
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Circ Heart Fail. 2016 Jun;9(6):
pubmed: 27266854
Int J Cardiol. 2017 Jan 15;227:820-825
pubmed: 27836303
N Engl J Med. 2017 Apr 27;376(17):1690-1692
pubmed: 28445660
Eur J Prev Cardiol. 2018 Mar;25(4):437-446
pubmed: 29327942
Eur J Prev Cardiol. 2018 Aug;25(12):1326-1340
pubmed: 29916723